259 related articles for article (PubMed ID: 27514754)
1. Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.
Würth R; Barbieri F; Pattarozzi A; Gaudenzi G; Gatto F; Fiaschi P; Ravetti JL; Zona G; Daga A; Persani L; Ferone D; Vitale G; Florio T
Mol Neurobiol; 2017 Sep; 54(7):4879-4895. PubMed ID: 27514754
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Mertens F; Gremeaux L; Chen J; Fu Q; Willems C; Roose H; Govaere O; Roskams T; Cristina C; Becú-Villalobos D; Jorissen M; Poorten VV; Bex M; van Loon J; Vankelecom H
Endocr Relat Cancer; 2015 Aug; 22(4):481-504. PubMed ID: 25921430
[TBL] [Abstract][Full Text] [Related]
3. Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.
Chen L; Ye H; Wang X; Tang X; Mao Y; Zhao Y; Wu Z; Mao XO; Xie L; Jin K; Yao Y
Cancer Lett; 2014 Jul; 349(1):61-6. PubMed ID: 24732807
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
[TBL] [Abstract][Full Text] [Related]
5. Isolation of tumour stem-like cells from benign tumours.
Xu Q; Yuan X; Tunici P; Liu G; Fan X; Xu M; Hu J; Hwang JY; Farkas DL; Black KL; Yu JS
Br J Cancer; 2009 Jul; 101(2):303-11. PubMed ID: 19568241
[TBL] [Abstract][Full Text] [Related]
6. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD133+ cells in pituitary adenomas.
Yunoue S; Arita K; Kawano H; Uchida H; Tokimura H; Hirano H
Neuroendocrinology; 2011; 94(4):302-12. PubMed ID: 21912092
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.
Zhao Y; Xiao Z; Chen W; Yang J; Li T; Fan B
Mol Med Rep; 2015 Aug; 12(2):2313-22. PubMed ID: 25937029
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators.
Drastikova M; Beranek M; Gabalec F; Netuka D; Masopust V; Cesak T; Marek J; Palicka V; Cap J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):238-43. PubMed ID: 26607296
[TBL] [Abstract][Full Text] [Related]
11. Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.
Donangelo I; Ren SG; Eigler T; Svendsen C; Melmed S
Endocr Relat Cancer; 2014 Apr; 21(2):203-16. PubMed ID: 24481638
[TBL] [Abstract][Full Text] [Related]
12. Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.
Würth R; Thellung S; Corsaro A; Barbieri F; Florio T
Front Endocrinol (Lausanne); 2020; 11():54. PubMed ID: 32153500
[TBL] [Abstract][Full Text] [Related]
13. [Isolation and preliminary identification of stem-like cells in pituitary adenoma].
Zhou PZ; Ma WC; Wang XJ; Cheng SW; Jiang S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):466-9. PubMed ID: 23898537
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenoma stem cells.
Tunici P; Yu JS
Methods Mol Biol; 2009; 568():195-201. PubMed ID: 19582428
[TBL] [Abstract][Full Text] [Related]
15. Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.
Gao Z; Cai L; Lu J; Wang C; Li Q; Chen J; Song X; Chen X; Zhang L; Zheng W; Su Z
Med Sci Monit; 2017 Apr; 23():1827-1833. PubMed ID: 28411401
[TBL] [Abstract][Full Text] [Related]
16. Dopamine 2 and somatostatin 1-5 receptors coexpression in clinically non-functioning pituitary adenomas.
Gabalec F; Drastikova M; Cesak T; Netuka D; Masopust V; Machac J; Marek J; Cap J; Beranek M
Physiol Res; 2015; 64(3):369-77. PubMed ID: 25536318
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
18. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
[TBL] [Abstract][Full Text] [Related]
19. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors.
Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S
J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]